2022
DOI: 10.3390/molecules27082427
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Deuterium-Labeled Vitamin D Metabolites as Internal Standards for LC-MS Analysis

Abstract: Blood levels of the vitamin D3 (D3) metabolites 25-hydroxyvitamin D3 (25(OH)D3), 24R,25-dihydroxyvitamin D3, and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) are recognized indicators for the diagnosis of bone metabolism-related diseases, D3 deficiency-related diseases, and hypercalcemia, and are generally measured by liquid-chromatography tandem mass spectrometry (LC-MS/MS) using an isotope dilution method. However, other D3 metabolites, such as 20-hydroxyvitamin D3 and lactone D3, also show interesting biological… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…2 In total synthesis, deuterium-labeled compounds have been used to modify the reaction selectivity. 3 H/D substitution plays also a major role in the development of new drugs and it serves, for instance, to increase their metabolic stability. 4 Interestingly, H/D substitution has also been reported to transform an achiral molecule into a chiral one.…”
mentioning
confidence: 99%
“…2 In total synthesis, deuterium-labeled compounds have been used to modify the reaction selectivity. 3 H/D substitution plays also a major role in the development of new drugs and it serves, for instance, to increase their metabolic stability. 4 Interestingly, H/D substitution has also been reported to transform an achiral molecule into a chiral one.…”
mentioning
confidence: 99%
“…More in detail, Nagata et al described the synthesis of deuterium-labelled vitamin D analogues with applications in the field of analytical chemistry [ 2 ]. Guo et al studied the derivatives of docosahexaenoic acid as candidates for the treatment of ovarian injury in vivo [ 3 ].…”
mentioning
confidence: 99%